Can Genetics Gear Maker Illumina Help Investors Crack The Code For Profits?

The market correction has taken its toll on many stocks but today we're going to look at one that's holding up fairly well – so far. It's Illumina (ILMN) and it makes tools that help scientists understand the ties between genetics and disease in order to come up with better treatments. Earnings growth ranged from 38% to 76% during the past three quarters. Sales growth came in between 45% and 50% during the same period. For the full year, analysts